Silke Marhenke

1.6k total citations
22 papers, 806 citations indexed

About

Silke Marhenke is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Silke Marhenke has authored 22 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Silke Marhenke's work include Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cancer-related Molecular Pathways (4 papers). Silke Marhenke is often cited by papers focused on Liver physiology and pathology (5 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cancer-related Molecular Pathways (4 papers). Silke Marhenke collaborates with scholars based in Germany, United States and Israel. Silke Marhenke's co-authors include Arndt Vogel, Michael P. Manns, Robert Geffers, Thomas Longerich, Jutta Lamlé, Laura Elisa Buitrago‐Molina, Masayuki Yamamoto, Reinhard von Wasielewski, C. J. Peter Eriksson and Jürgen Borlak and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Silke Marhenke

22 papers receiving 801 citations

Peers

Silke Marhenke
Elena Arriazu Spain
Romain Désert United States
Charles‐Henry Gattolliat France
Shinya Sakurai Japan
Masayoshi Horimoto Japan
Oihane García‐Irigoyen Spain
Pi‐Xiao Wang China
Ulrike A. Köhler Switzerland
Margaret Wilde United States
Elena Arriazu Spain
Silke Marhenke
Citations per year, relative to Silke Marhenke Silke Marhenke (= 1×) peers Elena Arriazu

Countries citing papers authored by Silke Marhenke

Since Specialization
Citations

This map shows the geographic impact of Silke Marhenke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silke Marhenke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silke Marhenke more than expected).

Fields of papers citing papers by Silke Marhenke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silke Marhenke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silke Marhenke. The network helps show where Silke Marhenke may publish in the future.

Co-authorship network of co-authors of Silke Marhenke

This figure shows the co-authorship network connecting the top 25 collaborators of Silke Marhenke. A scholar is included among the top collaborators of Silke Marhenke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silke Marhenke. Silke Marhenke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marhenke, Silke, Diana Becker, Tanja Poth, et al.. (2021). The Co‐mutational Spectrum Determines the Therapeutic Response in Murine FGFR2 Fusion‐Driven Cholangiocarcinoma. Hepatology. 74(3). 1357–1370. 14 indexed citations
2.
Buitrago‐Molina, Laura Elisa, Silke Marhenke, Diana Becker, et al.. (2021). p53-Independent Induction of p21 Fails to Control Regeneration and Hepatocarcinogenesis in a Murine Liver Injury Model. Cellular and Molecular Gastroenterology and Hepatology. 11(5). 1387–1404. 5 indexed citations
3.
Richter, Fabian, Sarah K. Williams, Katharina John, et al.. (2021). The TNFR1 Antagonist Atrosimab Is Therapeutic in Mouse Models of Acute and Chronic Inflammation. Frontiers in Immunology. 12. 705485–705485. 25 indexed citations
4.
Wandrer, Franziska, Silke Marhenke, Arndt Vogel, et al.. (2020). TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice. Cell Death and Disease. 11(3). 212–212. 111 indexed citations
5.
Marhenke, Silke, Matthias Hardtke‐Wolenski, Thomas Longerich, et al.. (2020). Absence of Atg7 in the liver disturbed hepatic regeneration after liver injury. Liver International. 40(5). 1225–1238. 20 indexed citations
6.
Kirstein, Martha M., Anika Großhennig, Silke Marhenke, et al.. (2020). The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis. Alimentary Pharmacology & Therapeutics. 51(11). 1160–1168. 14 indexed citations
7.
Scheiner, Bernhard, Torsten Voigtländer, Sandra Koch, et al.. (2019). Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma. Liver International. 39(4). 714–726. 48 indexed citations
8.
Saborowski, Anna, Katharina Wolff, Benedikt N. Beer, et al.. (2019). Murine Liver Organoids as a Genetically Flexible System to Study Liver Cancer In Vivo and In Vitro. Hepatology Communications. 3(3). 423–436. 34 indexed citations
9.
Kirstein, Martha M., Silke Marhenke, Wolfgang Koppert, et al.. (2017). Safety and efficacy of chemosaturation in patients with primary and secondary liver tumors. Journal of Cancer Research and Clinical Oncology. 143(10). 2113–2121. 24 indexed citations
10.
Stickel, Felix, Jonas Rosendahl, M.Y. Morgan, et al.. (2017). Genetic variation of PNPLA3 and TM6SF2 associate with hepatocellular carcinoma in patients with alcohol-related cirrhosis. Journal of Hepatology. 66(1). S174–S174. 1 indexed citations
11.
Dzieran, Johanna, Xiaodong Yuan, T Maass, et al.. (2017). Hepatocyte-specific Smad7 deletion accelerates DEN-induced HCC via activation of STAT3 signaling in mice. Oncogenesis. 6(1). e294–e294. 19 indexed citations
12.
Guigas, Bruno, et al.. (2015). C-Myc plays a crucial role in chronic liver injury. Journal of Viral Hepatitis. 22. 130–131. 1 indexed citations
13.
Buitrago‐Molina, Laura Elisa, Silke Marhenke, Robert Geffers, et al.. (2015). The BH3‐only protein BID impairs the p38‐mediated stress response and promotes hepatocarcinogenesis during chronic liver injury in mice. Hepatology. 62(3). 816–828. 7 indexed citations
14.
Buitrago‐Molina, Laura Elisa, Silke Marhenke, Thomas Longerich, et al.. (2013). The Degree of Liver Injury Determines the Role of P21 in Liver Regeneration And Hepatocarcinogenesis in Mice. Hepatology. 58(3). 1143–1152. 72 indexed citations
15.
Marhenke, Silke, Laura Elisa Buitrago‐Molina, Jessica Endig, et al.. (2013). p21 promotes sustained liver regeneration and hepatocarcinogenesis in chronic cholestatic liver injury. Gut. 63(9). 1501–1512. 43 indexed citations
16.
Pusterla, Tobias, Júlia Németh, Ilan Stein, et al.. (2013). Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice. Hepatology. 58(1). 363–373. 77 indexed citations
17.
Németh, Júlia, Tobias Pusterla, Christine Bauer, et al.. (2012). Hepatocyte-specific S100a8 and S100a9 transgene expression in mice causes Cxcl1 induction and systemic neutrophil enrichment. Cell Communication and Signaling. 10(1). 40–40. 16 indexed citations
18.
Buitrago‐Molina, Laura Elisa, Jutta Lamlé, Silke Marhenke, et al.. (2009). Rapamycin delays tumor development in murine livers by inhibiting proliferation of hepatocytes with DNA damage†. Hepatology. 50(2). 500–509. 36 indexed citations
19.
Marhenke, Silke, Jutta Lamlé, Laura Elisa Buitrago‐Molina, et al.. (2008). Activation of nuclear factor E2‐related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development†. Hepatology. 48(2). 487–496. 30 indexed citations
20.
Lamlé, Jutta, Silke Marhenke, Jürgen Borlak, et al.. (2008). Nuclear Factor-Eythroid 2–Related Factor 2 Prevents Alcohol-Induced Fulminant Liver Injury. Gastroenterology. 134(4). 1159–1168.e2. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elena Arriazu Breakdown of academic impact, for papers by Romain Désert Breakdown of academic impact, for papers by Charles‐Henry Gattolliat Breakdown of academic impact, for papers by Shinya Sakurai Breakdown of academic impact, for papers by Masayoshi Horimoto Breakdown of academic impact, for papers by Oihane García‐Irigoyen Breakdown of academic impact, for papers by Pi‐Xiao Wang Breakdown of academic impact, for papers by Ulrike A. Köhler Breakdown of academic impact, for papers by Margaret Wilde
Rankless by CCL
2026